Clinical trial
A Phase IIb, Multi-center, Randomized, Double-blind, Placebo-controlled Study, With Open-label Follow on, to Evaluate the Efficacy, Safety and Tolerability of PSD502 in Subjects With Premature Ejaculation (PE)
NCT00556478 is registered in ClinicalTrials.gov with Plethora Solutions Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIb, Multi-center, Randomized, Double-blind, Placebo-controlled Study, With Open-label Follow on, to Evaluate the Efficacy, Safety and Tolerability of PSD502 in Subjects With Premature Ejaculation (PE)
- Lead sponsor
- Plethora Solutions Ltd
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- October 31, 2009
- Enrollment
- 256 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.